People are running their own experiments with GLP-1s — with stunning results
GLP-1 drugs like Ozempic and Wegovy, originally developed for diabetes, are now being used by an estimated one in eight U.S. adults, primarily for weight loss but increasingly for unapproved conditions such as addiction, long COVID, and post-concussion syndrome. Journalist Julia Belluz ex
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Julia Belluz
conversational on Apple News Today
Mentions
Books, people, and resources mentioned in this episode.
People
Books
Companies
Products & Tools
Topics
Listen to This Episode
More from Apple News Today
Medicare will cover weight-loss drugs — but there’s a catch
Rebroadcast: The truth about Johnson & Johnson
The questions mounting for Maine’s Democratic Senate front-runner
Meet the MAHA influencer Trump wants as the “nation’s doctor”
Americans are obsessed with protein. How much do you actually need?
Trump reverses course on helping ships transit the Strait of Hormuz
Related episodes
From other shows on similar topics.
Skinny and sad on GLP-1s
Today, Explained
Reshaping the GLP-1 Economy: A Breaking Consumer Study
We Fixed It, You're Welcome
What we got wrong about GLP-1s
Search Engine
Ozempic for All?
The Daily
Rethinking addiction in the age of Ozempic
TED Radio Hour
Health Expert - Secrets Big Pharma Doesn’t Want You To Know | PBD #801
PBD Podcast
Get summaries like this every morning.
Free AI-powered recaps of Apple News Today and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.